News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,408 Results
Type
Article (87266)
Company Profile (738)
Press Release (770376)
Multimedia
Podcasts (165)
Webinars (26)
Section
Business (232989)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91213)
Employer Resources (201)
FDA (18249)
Job Trends (17388)
News (397229)
Policy (39905)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (119)
Alliances (56979)
ALS (137)
Alzheimer's disease (1649)
Antibody-drug conjugate (ADC) (206)
Approvals (18245)
Artificial intelligence (459)
Autoimmune disease (49)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (150)
Biotechnology (483)
Bladder cancer (118)
Brain cancer (47)
Breast cancer (439)
Cancer (3558)
Cardiovascular disease (312)
Career advice (3551)
Career pathing (36)
CAR-T (232)
CDC (51)
Cell therapy (633)
Cervical cancer (29)
Clinical research (74977)
Collaboration (1293)
Company closure (4)
Compensation (868)
Complete response letters (51)
COVID-19 (2941)
CRISPR (78)
C-suite (514)
Cystic fibrosis (130)
Data (3843)
Decentralized trials (2)
Denatured (59)
Depression (101)
Diabetes (429)
Diagnostics (7052)
Digital health (30)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (217)
Drug pricing (169)
Drug shortages (36)
Duchenne muscular dystrophy (183)
Earnings (98644)
Editorial (53)
Employer branding (25)
Employer resources (169)
Events (132462)
Executive appointments (958)
FDA (20504)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1144)
Gene editing (165)
Generative AI (45)
Gene therapy (501)
GLP-1 (1002)
Government (5353)
Grass and pollen (7)
Guidances (334)
Healthcare (20934)
HIV (48)
Huntington's disease (34)
IgA nephropathy (52)
Immunology and inflammation (227)
Immuno-oncology (19)
Indications (47)
Infectious disease (3161)
Inflammatory bowel disease (179)
Inflation Reduction Act (13)
Influenza (87)
Intellectual property (168)
Interviews (815)
IPO (17922)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (70)
Layoffs (628)
Leadership (31)
Legal (10144)
Liver cancer (90)
Longevity (12)
Lung cancer (512)
Lymphoma (251)
Machine learning (23)
Management (65)
Manufacturing (577)
MASH (121)
Medical device (14832)
Medtech (14850)
Mergers & acquisitions (22679)
Metabolic disorders (1089)
Multiple sclerosis (120)
NASH (23)
Neurodegenerative disease (186)
Neuropsychiatric disorders (50)
Neuroscience (2561)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (54)
Obesity (542)
Opinion (304)
Ovarian cancer (114)
Pain (156)
Pancreatic cancer (147)
Parkinson's disease (216)
Partnered (27)
Patents (387)
Patient recruitment (272)
Peanut (57)
People (66083)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23114)
Phase II (32560)
Phase III (24504)
Pipeline (2488)
Policy (282)
Postmarket research (3554)
Preclinical (10439)
Press Release (72)
Prostate cancer (176)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (606)
Real estate (7412)
Recruiting (76)
Regulatory (27722)
Reports (64)
Research institute (2677)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (121)
Series A (190)
Series B (142)
Service/supplier (30)
Sickle cell disease (77)
Special edition (25)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (95)
Tariffs (83)
The Weekly (104)
Vaccines (1013)
Venture capital (63)
Weight loss (377)
Women's health (56)
Worklife (21)
Date
Today (99)
Last 7 days (542)
Last 30 days (2472)
Last 365 days (33856)
2025 (23947)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (298)
Arkansas (14)
Asia (50817)
Australia (8925)
California (8962)
Canada (2719)
China (849)
Colorado (379)
Connecticut (401)
Delaware (243)
Europe (116700)
Florida (1318)
Georgia (305)
Hawaii (3)
Idaho (67)
Illinois (788)
India (47)
Indiana (434)
Iowa (19)
Japan (270)
Kansas (123)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1222)
Massachusetts (6747)
Michigan (297)
Minnesota (545)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (76)
New Jersey (2469)
New Mexico (32)
New York (2442)
North Carolina (1367)
North Dakota (10)
Northern California (3989)
Ohio (281)
Oklahoma (19)
Oregon (49)
Pennsylvania (1865)
Puerto Rico (18)
Rhode Island (44)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3412)
Tennessee (142)
Texas (1403)
United States (33234)
Utah (268)
Virginia (239)
Washington D.C. (82)
Washington State (771)
West Virginia (4)
Wisconsin (92)
There are 858,408 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
L7 Informatics Decodes the Platform Hype in Life Sciences: What Buyers Should Demand from Their Technology Partner Today
September 19, 2025
·
1 min read
Events
Oxford Nanopore Biopharma Day, Philadelphia
Invitation: Oxford Nanopore Biopharma Day, Philadelphia -- Register to join us on October 9th.
September 19, 2025
Invivyd
Vaccines
ACIP Day 2 Reveals Confusion, ‘Lack of Knowledge,’ on Revamped Committee
After a tension-packed two days that saw changes to the MMRV vaccine schedule and COVID-19 recommendations, as well as a delayed hepatitis B vaccine vote, policy experts expressed concern with the reconstituted committee’s dearth of previous experience and “understanding” of their role.
September 19, 2025
·
5 min read
·
Dan Samorodnitsky
RI Bio
Life Sciences PA
BioNJ
NewYorkBio
BioCT
Gene therapy
Bye Bye Bluebird: Gene Therapy Biotech Emerges From Private Buyout With Rebrand
Bluebird bio has re-emerged after a private equity buyout as Genetix Biotherapeutics, marking a return to its roots and a new path forward for manufacturing.
September 19, 2025
·
2 min read
·
Annalee Armstrong
1 of 85,841
Next
